CALA Stock, Calithera Biosciences Inc. Information
Stock Information
Get CALA Alerts
News, Short Squeeze, Breakout and More Instantly...
About Calithera Biosciences Inc.
Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the US. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its lead product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.